Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268596 (
EMA
)
2,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Band 3 protein accounts for the largest percentage of whole erythrocyte membrane proteins. Abnormalities in this protein are closely associated with pathologies including hereditary spherocytosis (HS),
Southeast Asian ovalocytosis
and distant renal tubular acidosis. Currently,
EMA
binding capacity measurement in erythrocytes is the most useful screening test for diagnosing HS. We have also demonstrated reduced
EMA
binding capacity in patients with HS who have deficiencies of membrane proteins such as ankyrin not directly binding to
EMA
and who have as yet undetectable abnormalities of membrane proteins. However, even patients with hereditary elliptocytosis, who have a partial spectrin deficiency, were found to show reduced
EMA
binding capacity. Six of 7 had spherocytic elliptocytosis. Therefore, it is necessary to meticulously diagnose HS by ruling out all other possibilities.
...
PMID:[Band 3 deficiency as a cause of hereditary spherocytosis]. 2625 Nov 47